Teligent
TLGT
#10146
Rank
โ‚ฌ13.9 M
Marketcap
0,15ย โ‚ฌ
Share price
-13.85%
Change (1 day)
1,493.91%
Change (1 year)
Teligent is an American pharmaceutical company that develops and markets injectable and topical prescription medicines.

Revenue for Teligent (TLGT)

Revenue in 2021 (TTM): โ‚ฌ38.98 Million

According to Teligent's latest financial reports the company's current revenue is โ‚ฌ39.96 Million. In 2020 the company made a revenue of โ‚ฌ39.11 Million a decrease over the revenue in the year 2019 that were of โ‚ฌ56.88 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Teligent from 2001 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)โ‚ฌ38.98 M-0.33%
2020โ‚ฌ39.11 M-31.24%
2019โ‚ฌ56.88 M-0.71%
2018โ‚ฌ57.29 M-1.31%
2017โ‚ฌ58.05 M0.55%
2016โ‚ฌ57.73 M51.14%
2015โ‚ฌ38.2 M31.15%
2014โ‚ฌ29.12 M85.15%
2013โ‚ฌ15.73 M112.81%
2012โ‚ฌ7.39 M9.7%
2011โ‚ฌ6.73 M28.07%
2010โ‚ฌ5.26 M61.33%
2009โ‚ฌ3.26 M-7.15%
2008โ‚ฌ3.51 M-11.18%
2007โ‚ฌ3.95 M74.85%
2006โ‚ฌ2.26 M-8.62%
2005โ‚ฌ2.47 M-8.84%
2004โ‚ฌ2.71 M-11.58%
2003โ‚ฌ3.07 M-51.95%
2002โ‚ฌ6.39 M-54.52%
2001โ‚ฌ14.05 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
OPKO Health
OPK
โ‚ฌ0.55 B 1,286.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
โ‚ฌ0.19 M-99.51%๐Ÿ‡บ๐Ÿ‡ธ USA